Skip to main content
. 2005 Sep 21;3:48. doi: 10.1186/1477-7827-3-48

Figure 1.

Figure 1

Experimental design. Male hpg mice were treated with either vehicle (VEH) or 100 μg testosterone propionate (TP) on postnatal day 2, then received a subcutaneous silastic capsule containing either cholesterol (chol) or 2% estradiol in cholesterol on day 35 of age.

HHS Vulnerability Disclosure